Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2007
12/26/2007EP1869037A1 Heterobicylic inhibitors of hvc
12/26/2007EP1869036A1 Substituted 1,5-naphthyridine azolidinones as cdk inhibitors
12/26/2007EP1869021A1 Dna-pk inhibitors
12/26/2007EP1868986A1 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics
12/26/2007EP1868605A2 Phenyl and pyridyl lta4h modulators
12/26/2007EP1539750B1 Pyrazolopyridines as cyclin dependent kinase inhibitors
12/26/2007EP1539708B1 Benzimidazolones and their use as cytokine inhibitors
12/26/2007EP1187835B1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
12/26/2007CN101094852A Substituted indolizines and derivatives as cns agents
12/26/2007CN101094848A Organic compounds
12/26/2007CN101094838A Tubulin binding anticancer agents and prodrugs thereof
12/26/2007CN101094670A Oxime substituted imidazoquinolines
12/26/2007CN101092432A Superoxide dismutase mimics for the treatment of ocular disorders and diseases
12/26/2007CN101092400A 黄嘌呤氧化酶抑制剂 Xanthine oxidase inhibitors
12/26/2007CN100357326C Method for producing aqueous polymer dispersions containing colorants
12/26/2007CN100357296C Method for processing production raw materials of vinca alkaloid
12/26/2007CN100356979C Integrin expression inhibitors
12/25/2007US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
12/25/2007US7312334 Reacting ethyl-1-(3-acetylenylphenyl)-1,4-dihydro(1,8)naphthyridin-4-one-3-carboxylate with 3- bromopyridine in palladium catalyst, phosphine ligand and amine base, and them amidating the ester with cyclopropylamine; one pot process
12/25/2007US7312333 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease
12/25/2007US7312332 Such as 1-butyl-3-hydroxy-1-[2-hydroxy-3-(1-oxyl-2,2,6,6-tetramethyl-piperidin-4-yloxy)-propyl]-azetidinium chloride; yellowing and discoloration prevention; ultraviolet, fluorescent and solar light stability; expanding use of high yield pulps to higher grade products
12/25/2007US7312330 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
12/25/2007US7312326 Fluorescent labeled nucleotide derivatives
12/25/2007US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007US7312231 Quaternization of compound for treatment of urogenital disorders, respiratory system disorders or gastrointestinal disorders
12/25/2007US7312228 Cytotoxic indeno and isoindoloisoquinolones
12/25/2007US7312224 Pyrimidine derivatives
12/25/2007US7312218 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide
12/25/2007US7312214 Anticoagulants; atherosclerosis; strokes; thrombosis; cardiovascular disorders
12/25/2007US7312212 Bactericides for infrections in man
12/25/2007US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/21/2007WO2007146831A2 Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
12/21/2007WO2007146250A2 Naphthalene-based semiconductor materials and methods of preparing and use thereof
12/21/2007WO2007146124A2 Deuterated tadalafil derivatives
12/21/2007WO2007146087A2 SUBSTITUTED PYRAZOLO [1,5-α] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE
12/21/2007WO2007145213A1 Control of the formation of double-stranded dna
12/21/2007WO2007144204A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007WO2007144203A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/21/2007WO2007144202A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007WO2007144200A1 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement
12/21/2007WO2007106236A3 Pyrrolo-pyridine kinase modulators
12/21/2007WO2007086080A3 NOVEL IMIDAZO[1,2-a]PYRIDINE CANNABINOID RECEPTOR LIGANDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
12/21/2007WO2007081517A3 Anti-viral compounds
12/21/2007WO2007063418A3 Substituted indole compounds having nos inhibitory activity
12/21/2007WO2006083916A3 Novel adenosine a3 receptor modulators
12/21/2007WO2006036395A3 Inhibitors of akt activity
12/21/2007CA2655085A1 Cgrp receptor antagonists
12/21/2007CA2654987A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007CA2654789A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007CA2654515A1 Substituted 3-cyanopyridines as protein kinase inhibitors
12/21/2007CA2654498A1 Substituted pyrazolo[1,5-.alpha.]pyridine compounds and their methods of use
12/21/2007CA2654105A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/20/2007US20070293678 Process For The Preparation Of 6, 8-Subs Tituted '1, 7 Naphthpyridin Derivatives By Reacting The 8-Halo-'1, 7 Naphthpyrid In-Derivate With An Organic Boronic Acid Derivatives And Intermadiates Of This Process
12/20/2007US20070293677 Process for the Preparation of Cabergoline
12/20/2007US20070293671 Process for the Preparation of Risperidone
12/20/2007US20070293670 Pyrrolopyrimidine and Pyrrolopyridine Derivatives Substituted with Tetrahydropyridine as Crf Antagonists
12/20/2007US20070293532 Pyrrolo [2,3-C] Pyridine Compound, Process for Producing the Same, and Use
12/20/2007US20070293530 Sulfamide and sulfamate derivatives as histone deacetylase inhibitors
12/20/2007US20070293528 non-steroidal partial activators and/or tissue-specific activators or inhibtors for androgen receptors, used for treating acne, alopecia, hirsutism, prostatic hyperplasia or prostate cancer
12/20/2007US20070293527 1-Methyl-1,3,4,5,6,11b-hexahydro-2H-11-oxa-4a-aza-benzo[a]fluoren-1-ol; alpha 2C adrergic receptors; adrenergic blocking agents; central nervous system; cognition activators; antidepressants; anxiolytic agents; peripheral nervous syster; antidiabetic agents; hypertensive agents; Raynaud's disease
12/20/2007US20070293508 Crf Receptor Antagonists and Methods Relating Thereto
12/20/2007US20070293500 Quinazoline derivatives as medicaments
12/20/2007US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007US20070293488 tyrosine kinase inhibitors such as 1-(2-fluoro-5-trifluoromethylphenyl)-3-[4-(5-oxo-5,8-dihydropyrido[2,3-d]pyrimidin-4-ylamino)phenyl]urea, used as antitumor or anticarcinogenic agents or for the treatment of psoriasis, arthritis, retinopathy or dermatitis
12/20/2007US20070293456 Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds
12/20/2007US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease
12/20/2007US20070292471 Nitric Oxide-Releasing Diazeniumdiolated Acrylonitrile-Based Polymers, and Compositions, Medical Devices, and Uses Thereof
12/19/2007EP1867648A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.
12/19/2007EP1867647A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.
12/19/2007EP1867645A1 Variolin derivatives and their use as antitumor agents
12/19/2007EP1867638A1 Procedure for the Conection of two Molecules via Diels-Alder Reactions with Inverse Electron Demand
12/19/2007EP1866315A1 1,2,4-triazole derivatives and their use as oxytocin antagonists
12/19/2007EP1866310A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists
12/19/2007EP1866309A1 A method of preparing a porphyrin derivative, a porphyrin derivative, use of said porphyrin
12/19/2007EP1866308A1 Preparation of a high purity substituted quinoxaline
12/19/2007EP1866307A1 Synthesis of pyrroloquinoline quinone (pqq)
12/19/2007EP1866306A1 Imidazopyridine derivatives useful as inos inhibitors
12/19/2007EP1866305A1 1,7-naphthyridines as pde4 inhibitors
12/19/2007EP1866292A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/19/2007EP1865959A2 Process for preparing pyridoý2,3-d¨pyrimidin-7-one and 3,4-dihydropyrimidoý4,5-d¨pyrimidin-2(1h)-one derivatives
12/19/2007EP1781656B1 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
12/19/2007EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
12/19/2007EP1594869B1 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
12/19/2007EP1503757B1 Tyrosine kinase inhibitors
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007EP1292596B1 1,3,8-triaza-spiro¬4,5 decan-4-one derivatives as neurokinin receptor antagonists
12/19/2007EP1286999B1 PYRANO[2,3-c]IMIDAZO[1,2-a]PYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
12/19/2007EP0804440B1 Tricyclic benzazepine vasopressin antagonists
12/19/2007CN101090901A Hexahydropyridoisoqinolines as DPP-IV inhibitors
12/19/2007CN100355755C Diazabicyclic central nervous system active agents
12/19/2007CN100355728C Inhibitors of dipeptidyl peptidase IV
12/18/2007US7309790 Chemical compounds
12/18/2007US7309789 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
12/18/2007US7309703 Substituted pyrazoles useful for treating autoimmune diseases mediated by cathepsin S
12/18/2007US7309700 Crystalline dihydrate is more resistant to heat and humidity than the trihydrate; storage stability
12/13/2007WO2007143468A2 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
12/13/2007WO2007143446A1 Spiro-condensed heterotricyclic compounds as hiv integrase inhibitors
12/13/2007WO2007142585A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
12/13/2007WO2007141504A1 Fused thiophene derivatives as kinase inhibitors
1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 646